000 01388 a2200361 4500
005 20250517160900.0
264 0 _c20170818
008 201708s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2017.05.074
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQi, Xiang-Yu
245 0 0 _aDiscovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_c08 2017
300 _a3511-3515 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aDrug Discovery
650 0 4 _aEnzyme Inhibitors
_xchemistry
650 0 4 _aHumans
650 0 4 _aMembrane Proteins
_xantagonists & inhibitors
650 0 4 _aMolecular Docking Simulation
650 0 4 _aNerve Tissue Proteins
_xantagonists & inhibitors
650 0 4 _aOxazoles
_xchemistry
650 0 4 _aPyridines
_xchemistry
650 0 4 _aTransferases (Other Substituted Phosphate Groups)
_xantagonists & inhibitors
700 1 _aCao, Yang
700 1 _aLi, Ya-Li
700 1 _aMo, Ming-Guang
700 1 _aZhou, Lu
700 1 _aYe, De-Yong
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 27
_gno. 15
_gp. 3511-3515
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2017.05.074
_zAvailable from publisher's website
999 _c27282321
_d27282321